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BACKGROUND: 
• Polypharmacy within adults with multimorbidities is a significant challenge for global healthcare systems (1).
• Previous reviews have not fully explored the different cultural, organisational, interpersonal and individual-level barriers
and facilitators to safe deprescribing in patients with multimorbidities and polypharmacy in primary care (2).
• Using a socio-ecological approach, this review aimed to identify the barriers and facilitators to safe deprescribing for adults
with multimorbidities and polypharmacy in primary care settings.
• This work is linked to UN Sustainability Development Goal 3 ‘Good health and well-being’, Target 3.8 – ‘Achieve universal
health coverage, including financial risk protection, access to quality essential health-care services and access to safe,
effective, quality and affordable essential medicines and vaccines for all’.
METHODS:
A systematic review of studies published in 2000 - 2019 examining barriers and facilitators to safe deprescribing interventions 
for patients with multimorbidities and polypharmacy.
RESULTS:
40 studies from 14 different countries were included in the review.  The review found complex cultural, organisational, 
interpersonal and individual level barriers to deprescribing in patients with multimorbidities and polypharmacy in primary care,
and suggested facilitators to address these:
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CONCLUSION
A whole systems patient-centred approach to safe deprescribing interventions is required, involving key decision-makers, 
healthcare professionals, patients and carers.
ORGANISATIONAL
INTERPERSONAL
• Prescribing culture – diagnosis and 
prescribing new medications  
• Lack of non-pharmaceutical alternatives
• Single disease focused evidence-base 
and guidance
• Lack of guidance on interactions of 
different medications
• Insufficient tools and resources
• Fragmented care 
• Prescriber uncertainties 
• Reluctance to cease medication started 
by another specialist.
• Fears about the adverse affects of 
stopping a medication 
• Patient may not want to cease long-term 
medications
• Patients put trust in their doctor and may 
have attitude of  “doctor knows best”
• Patient may have cognitive impairment 
and be reliant on the support of others
• A prudent prescribing culture
• Better evidence-based multimorbidities 
guidance 
• Improved communication between patient, 
doctor and other health and social care 
providers
• Continuity of care
• Closer collaboration between pharmacists, 
GPs and other interdisciplinary services
• Improved prescriber and patient awareness, 
understanding and knowledge
• Patient centred care and patient involvement 
in decision-making
• Patient wanting to take fewer medications
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